The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.
Eligibility
Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Prostate cancer survivors treated in our department by hypofractionated radiotherapy
Exclusion Criteria:
* Relapse of prostate cancer
* Other active cancer
* Mental disorder
Primary outcome measure(s)
faecal incontinence after prostate radiation therapy — before radiotherapy (basal) grade of faecal incontinence in prostate cancer patients
faecal incontinence after prostate radiation therapy — change 2 years after completion of radiotherapy grade of faecal incontinence in prostate cancer survivors
faecal incontinence after prostate radiation therapy — change 3 years after completion of radiotherapy grade of faecal incontinence in prostate cancer survivors
faecal incontinence after prostate radiation therapy — change 4 years after completion of radiotherapy grade of faecal incontinence in prostate cancer survivors
faecal incontinence after prostate radiation therapy — change 5 years after completion of radiotherapy grade of faecal incontinence in prostate cancer survivors
Trial sites (1)
Facility
City
Region
Status
Consorci Sanitari de Terrassa
Terrassa
Catalonia
More Consorci Sanitari de Terrassa trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
